Stefania Mosconi

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Roberto Labianca, Bernard Nordlinger, Giordano Beretta et al. · Annals of Oncology · 2013 · 1.4K citations · Full text

Medicine, Oncology, Surgery +14

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini et al. · The Lancet Oncology · 2020 · 325 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Assessment of a HER2 scoring system for colorectal cancer: results from a validation study

Emanuele Valtorta, Cosimo Martino, Andrea Sartore‐Bianchi et al. · Modern Pathology · 2015 · 317 citations · Full text

Medicine, Oncology, Pathology +13

Safety and efficacy of preoperative or postoperative chemotherapy for resectable pancreatic adenocarcinoma (PACT-15): a randomised, open-label, phase 2–3 trial

Michele Reni, Gianpaolo Balzano, Silvia Zanon et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 254 citations

Medicine, Oncology, Surgery +10